News Wire
Study: Children with ASD More Than Twice as Likely to Suffer From Food Allergies
“This indicates there could be a shared mechanism linking different types of allergic conditions to ASD.”
Food Allergy Research & Education Names Lisa Gable Chief Executive Officer
Executive with Business, Government and Nonprofit Leadership Experience Selected to Lead National Food Allergy Organization
Senator Durbin Presses FDA And Drug Manufacturer For Information On Epipen Shortages
Senator Urges FDA Commissioner To Take Any and All Steps Necessary To Quickly Remedy This Potentially Life-Threatening Situation
European Study Shows Significant Psychosocial Burden Associated with Peanut Allergy
Data discussed at EAACI 2018 reveal uncertainty, bullying and high levels of anxiety around food.
Study Identifies Food Allergy Policies Parents Want to Improve Safety of Kids in Schools
One in five parents did not feel that their child with food allergy was safe while at school, according to results of a national survey.
Study: Dupilumab Showed Positive Phase 3 Results in Adolescents with Inadequately Controlled Eczema
"[dupilumab] blocks the IL-4/IL-13 pathway, which is emerging as a central driver of Type 2 allergic inflammation."
Study: IgG Antibodies Activate Blood Platelets and Contribute to the Severity of Anaphylaxis
"This work demonstrates the potential of exploring therapeutic interventions that target platelets as means of limiting the severity of anaphylactic shock."
Bacteria Therapy for Eczema Shows Promise in NIH Study
"We aim to alter the skin microbiome in a way that will relieve symptoms and free people from the burden of constant treatment."
FARE Calls on FDA to Act Swiftly On Reported EpiPen Shortage
The American Society of Health-System Pharmacists determined there was a national shortage of epinephrine auto-injectors covering two of the three manufacturers.
Discovery Could Lead To Personalized Medical Therapies for Emerging New Food Allergy Disorder
"Our goal is to provide the type of deep disease understanding and therapeutic decision-making that is now becoming routine in the cancer field."
